189 related articles for article (PubMed ID: 25574915)
21. Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC; Salomon JA; Murray M; Weinstein MC
PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
[TBL] [Abstract][Full Text] [Related]
22. Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.
Lu X; Smare C; Kambili C; El Khoury AC; Wolfson LJ
BMC Health Serv Res; 2017 Jan; 17(1):87. PubMed ID: 28122562
[TBL] [Abstract][Full Text] [Related]
23. The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa.
Mpobela Agnarson A; Williams A; Kambili C; Mattson G; Metz L
Expert Rev Anti Infect Ther; 2020 May; 18(5):475-483. PubMed ID: 32186925
[No Abstract] [Full Text] [Related]
24. Improving rifampicin-resistant tuberculosis diagnosis using Xpert
Dunbar R; Naidoo P; Beyers N; Langley I
Int J Tuberc Lung Dis; 2018 Aug; 22(8):890-898. PubMed ID: 29991398
[TBL] [Abstract][Full Text] [Related]
25. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
[TBL] [Abstract][Full Text] [Related]
26. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
[TBL] [Abstract][Full Text] [Related]
27. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
van Rensburg C; Berhanu R; Hirasen K; Evans D; Rosen S; Long L
PLoS One; 2019; 14(6):e0217820. PubMed ID: 31170207
[TBL] [Abstract][Full Text] [Related]
28. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
[TBL] [Abstract][Full Text] [Related]
29. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
Hanrahan CF; Dorman SE; Erasmus L; Koornhof H; Coetzee G; Golub JE
PLoS One; 2012; 7(11):e49898. PubMed ID: 23226229
[TBL] [Abstract][Full Text] [Related]
30. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
Laurence YV; Griffiths UK; Vassall A
Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
[TBL] [Abstract][Full Text] [Related]
31. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES
BMC Infect Dis; 2017 Jan; 17(1):36. PubMed ID: 28061832
[TBL] [Abstract][Full Text] [Related]
32. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
Evans D; Schnippel K; Govathson C; Sineke T; Black A; Long L; Berhanu R; Rosen S
PLoS One; 2017; 12(7):e0181238. PubMed ID: 28746344
[TBL] [Abstract][Full Text] [Related]
33. MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
Loveday M; Wallengren K; Reddy T; Besada D; Brust JCM; Voce A; Desai H; Ngozo J; Radebe Z; Master I; Padayatchi N; Daviaud E
PLoS One; 2018; 13(4):e0196003. PubMed ID: 29668748
[TBL] [Abstract][Full Text] [Related]
34. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
[TBL] [Abstract][Full Text] [Related]
35. Cost of multidrug resistant tuberculosis in Germany-An update.
Diel R; Sotgiu G; Andres S; Hillemann D; Maurer FP
Int J Infect Dis; 2021 Feb; 103():102-109. PubMed ID: 33157286
[TBL] [Abstract][Full Text] [Related]
36. Time-to-Treatment Initiation in a Decentralised Community-Care Model of Drug-Resistant Tuberculosis Management in the OR Tambo District Municipality of South Africa.
Iruedo JO; Pather MK
Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510655
[TBL] [Abstract][Full Text] [Related]
37. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
[TBL] [Abstract][Full Text] [Related]
38. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
[TBL] [Abstract][Full Text] [Related]
39. Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.
De Vos E; Scott L; Voss De Lima Y; Warren RM; Stevens W; Hayes C; da Silva P; Van Rie A
Int J Tuberc Lung Dis; 2021 Feb; 25(2):134-141. PubMed ID: 33656425
[No Abstract] [Full Text] [Related]
40. Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
Cox H; Goig GA; Salaam-Dreyer Z; Dippenaar A; Reuter A; Mohr-Holland E; Daniels J; Cudahy PGT; Nicol MP; Borrell S; Reinhard M; Doetsch A; Beisel C; Gagneux S; Warren RM; Furin J
J Clin Microbiol; 2022 Mar; 60(3):e0236221. PubMed ID: 35170980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
